https://doi.org/10.4081/mem.2019.596
"Unsustainable drugs" and intergenerational healthcare justice
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The recent introduction of new direct-acting antiviral drugs for the treatment of patients with hepatitis C that are extremely effective in treating the disease but that are associated with exorbitant costs raised public debate about healthcare distributive justice. The aim of this article is to provide a brief discussion on the topic of the so-called "unsustainable drugs" examined under a specific model of distributive justice, i.e. egalitarianism, and from an intergenerational perspective. The conclusion is that to date healthcare systems are facing the issue of sustainability through the optimization of pharmaceutical spending, but they are not well equipped to face the possibility of an inevitable divergence between demand and supply of this kind of drugs. The latter should be addressed with reference to the conception of distributive justice of a certain society, and in particular, to the amount of resources that a society wishes to pay for the treatment of one of its member. Finally, in terms of distributive justice, the argument - which is often supported by pharmacoeconomic evaluations - according to which the vast amount of money spent now for this type of drugs will allow to have savings in the long run is not in itself coherent with the main theories of justice. Considerations that are extrinsic to the assumptions of the main theories of justice are needed in order to justify the argument above.
How to Cite
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
An Open Access Publication is one that meets the following two conditions:
- the author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
- a complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.